A classifier driven approach to find biomarkers for affective disorders from transcription profiles in blood
Journal Title: Advances in Precision Medicine - Year 2016, Vol 1, Issue 1
Abstract
Gene expression profiles in blood are increasingly being used to identify biomarkers for different affective disorders. We have selected a set of 29 genes to generate expression profiles for healthy control subjects as well as for patients diagnosed with acute post-traumatic stress disorder (PTSD) and with borderline personality disorder (BPD). Measurements were performed by quantitative polymerase chain reaction (qPCR). Using the actual data in an anonymous form we constructed a series of artificial data sets with known gene expression profiles. These sets were used to test 14 classification algorithms and feature selection methods for their ability to identify the correct expression patterns. Application of the three most effective algorithms to the actual expression data showed that control subjects can be distinguished from BPD patients based on differential expression levels of the gene transcripts Gi2, GR and MAPK14, targets that may have links to stress related diseases. Controls can also be distinguished from acute PTSD patients by differential expression levels of the transcripts for ERK2 and RGS2 that are known to be associated with mood disorders and social anxiety. We conclude that it is possible to identify informative transcription profiles in blood samples from individuals with affective disorders.
Authors and Affiliations
Wiktor Mazin, Joseph A. Tamm, Irina A. Antonijevic, Aicha Abdourahman, Munish Das,Roman Artymyshyn, Birgitte Søgaard, Mary Walker, Danka Savic, Gordana Matic, Svetozar Damjanović, Ulrik Gether, Thomas Werge, Lars V. Kessing, Henrik Ullum, Eva Haastrup, Eric Vermetten, Paul Markovitz, Erik Mosekilde and Christophe P. G. Gerald
Keywords
Related Articles
- EP ID EP679278
- DOI -
- Views 170
- Downloads 0
The SMART healthcare solution
Substitutable Medical Apps Reusable Technologies (SMART®) on Fast Healthcare Interoperability Resources (FHIR) is an open, standards platform that allows third parties to build health applications that interact with elec...
Validation of novel multiplex technologies
Cytokine and chemokine levels in body fluid provide information of altered conditions in patients. The parallel analysis of multiple factors, such as cytokines, from small sample sizes is an interesting approach for the...
Genomics Vault: A framework for precision medicine data management
A mixture of fumaric acid esters (FAEs) is approved for the oral therapy of psoriasis. However, for a long time the active ingredient of this mixture was unknown. We reviewed the in vitro data available for the different...
Personalized medicine: consequences for drug research and therapy
In drug research, a serious transformation has taken place. With increasing knowledge gained from molecular medicine, it became possible to refine and develop new therapies based on the molecular mechanisms of diseases....
Identifying the active pharmaceutical ingredient from a mixture of fumaric acid esters for the treatment of psoriasis: Hints from in vitro investigations
A mixture of fumaric acid esters (FAEs) is approved for the oral therapy of psoriasis. However, for a long time the active ingredient of this mixture was unknown. We reviewed the in vitro data available for the different...